EUVIMEDEUVIMED entdecken
Crossref

Who Can Benefit From a Cancer Genetic Evaluation? Considerations for Genetic Risk Evaluation and Testing Based on Tumor Type and Pathology

Karina L. Brierley, Elizabeth Charnysh, Amanda Ganzak, Claire Healy, Allen E. Bale

JCO Oncology Advances · 2026-04 · 3 (2)

DOI: 10.1200/oa-25-00106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Advances, 2026-04. Verfasst von Karina L. Brierley und 4 weiteren Autor:innen. Die Arbeit nennt 213 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer genetic counseling and testing have become integral to medicine given expanding knowledge of genetic risk and recognition that a substantial fraction of cancer is hereditary. Access to genetic testing and precision medicine breakthroughs have led to new standards of care for diagnosis and treatment. Many tumor types, both common (eg, breast cancer) and rare (eg, pheochromocytoma), are associated with hereditary cancer syndromes. Even common tumors typically explained by exposures might have important genetic underpinnings (eg, lung cancer in nonsmokers, skin cancer in dark-complexioned individuals). Cancer genetics referral determination is nuanced, requiring consideration of specific tumor characteristics and other factors (eg, age at diagnosis, personal and/or family history). This publication is intended as a resource for oncology providers to make such determinations.

Zitieren

APA

Brierley, K. L., Charnysh, E., Ganzak, A., Healy, C., & Bale, A. E. (2026). Who Can Benefit From a Cancer Genetic Evaluation? Considerations for Genetic Risk Evaluation and Testing Based on Tumor Type and Pathology. JCO Oncology Advances, 3(2). https://doi.org/10.1200/oa-25-00106

Vancouver

Brierley KL, Charnysh E, Ganzak A, Healy C, Bale AE. Who Can Benefit From a Cancer Genetic Evaluation? Considerations for Genetic Risk Evaluation and Testing Based on Tumor Type and Pathology. JCO Oncology Advances. 2026;3(2). doi:10.1200/oa-25-00106

BibTeX
@article{Brierley2026,
  author = {Brierley, Karina L. and Charnysh, Elizabeth and Ganzak, Amanda and Healy, Claire and Bale, Allen E.},
  title = {Who Can Benefit From a Cancer Genetic Evaluation? Considerations for Genetic Risk Evaluation and Testing Based on Tumor Type and Pathology},
  journal = {JCO Oncology Advances},
  year = {2026},
  volume = {3},
  number = {2},
  doi = {10.1200/oa-25-00106}
}
Kostenlos starten →